| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V5069 | Metaxalone (AHR438;NSC170959) | 1665-48-1 | Metaxalone(also known as AHR438; NSC170959) is a skeletal muscle relaxant prescribed for the short-term treatment of painful muscle spasmscaused by strains, sprains, and other musculoskeletal conditions. |
|
V5088 | Methoxyamine HCl | 593-56-6 | Methoxyamine HCl is a novel, potent and orally bioavailable small molecule inhibitor with potential adjuvant activity. |
|
V5137 | Miconazole Nitrate | 228321-87-7 | Miconazole Nitrate is a potent imidazole-based antifungal agent that is commonly used by topical administration to the skin or to mucous membranes to cure fungal infections. |
|
V5016 | NSC-41589 | 6310-41-4 | NSC-41589 is N-[2-(methylsulfanyl) phenyl]acetamide. |
|
V5041 | NSC139021 (ERGi-USU) | 1147-56-4 | NSC139021 (also known as ERGi-USU) is a novel, potent and highly selective inhibitor for the growth of ERG-positive cancer cells with IC50s ranging from 30 to 400 nM. |
|
V4875 | Onalespib lactate | 1019889-35-0 | Onalespib (formerly also known as AT13387; AT-13387) is an orally bioavailable small-molecule Hsp90 inhibitor (IC50 = 18 nM in A375 cells) with long-lasting anti-tumor activity. |
|
V4780 | PCI-27483 | 871266-63-6 | PCI-27483 is a novel, potent and reversible small-molecule inhibitor of activated factor VII (factor VIIa) with potential anticancer and antithrombotic activities. |
|
V2174 | RETV804M inhibitor | 2414373-42-3 | RET-IN-21 is a receptor tyrosine kinase (RET) inhibitor (antagonist) with IC50 of 4.4 μM and anti-tumor activity. |
|
V4811 | Ro 10-5824 | 189744-46-5 | Ro 10-5824 is a novel, potent and selectivepartial agonist of dopamine D4 receptorwithKiof 5.2 nM. |
|
V4611 | SB-224289 HCL | 180083-23-2 | SB-224289 hydrochloride is a novel, potent and selective5-HT1B receptorantagonist with anxiolytic effect with pKi of 8.2. |
|
V2164 | SC-26196 | 218136-59-5 | SC-26196 is a novel, potent and orally bioactive D6D (Delta6 desaturase) inhibitor with IC50 of 0.2 µM in a rat liver microsomal assay. |
|
V4670 | SCH00013 | 217963-18-3 | SCH00013 is a novel and potent Ca2+ sensitizer that elicits a moderate positive inotropic effect without significant alteration of Ca2+ transients. |
|
V4800 | SJA710-6 | 1397255-09-2 | SJA710-6 (a Hepatic Differentiation Inducer) is a novel, potent and cell-permeable small moleculeimidazopyridinamine compound that is able to induce the differentiation of rat MSCs (rMSCs) toward hepatocyte-like cells(~47% at 5 µM). |
|
V5053 | SKI-II HCl | 1177741-83-1 | SKI-II HCl is a substrate competitive, reversible, and highly specific inhibitor of sphingosine kinase. |
|
V4597 | Sufugolix (TAK013) | 308831-61-0 | Sufugolix (formerly known as TAK-013) is a novel, highly potent,non-peptide, selective and orally bioavailable luteinizing hormone-releasing hormone (LHRH) receptor antagonist with anticancer activity. |
|
V4906 | Talampanel | 161832-65-1 | Talampanel (also known as LY300164; LY-300164 and GYKI-53773) is a novel, potent, orally bioavailable and selective α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor antagonis with anti-seizure activity. |
|
V5197 | Teixobactin | 1613225-53-8 | Teixobactin, a naturally occuring antibiotic discovered in a screen of uncultured bacteria, is a novel peptide-like secondary metabolite of some species of bacteria, that kills some gram-positive bacteria, and has the the potential to overcome drug resistance. |
|
V5058 | TP-2857 | 1575491-01-8 | TP-2857 is novel and potent antimicrobial compound. |
|
V4594 | U83836E | 137018-55-4 | U83836E is a novel and potent lipid peroxidation (LP) inhibitor. |
|
V4622 | Zotiraciclib (SB1317) HCl | 1354567-82-0 | Zotiraciclib (SB1317; TG02) HCl, the hydrochloride salt of SB1317, is a novel and potent small molecule inhibitor ofCDK2,JAK2, andFLT3 with the potential for the treatment of cancer. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
